SEC Filings

10-Q
ENVISION HEALTHCARE CORP filed this Form 10-Q on 11/03/2017
Entire Document
 
Item 1. Financial Statements - (continued)

Insurance collateral consisted of the following as of September 30, 2017 and December 31, 2016 (in millions):
 
September 30, 2017
 
December 31, 2016
Available-for-sale securities:
 
 
 
U.S. Treasuries
$
1.7

 
$
1.0

Corporate bonds/Fixed income
42.8

 
28.3

Corporate equity
12.2

 
14.2

Total available-for-sale securities
56.7

 
43.5

Cash deposits and other
45.8

 
43.5

Insurance collateral
$
102.5

 
$
87.0


Amortized cost basis and aggregate fair value of the Company's available-for-sale securities as of September 30, 2017 and December 31, 2016 were as follows (in millions):
 
September 30, 2017
 
 
 
Gross
 
Gross
 
 
 
Cost
 
Unrealized
 
Unrealized
 
Fair
 
Basis
 
Gains
 
Losses
 
Value
Description:
 
 
 
 
 
 
 
U.S. Treasuries
$
1.7

 
$

 
$

 
$
1.7

Corporate bonds/Fixed income
42.5

 
0.5

 
(0.2
)
 
42.8

Corporate equity
10.5

 
1.8

 
(0.1
)
 
12.2

Total available-for-sale securities
$
54.7

 
$
2.3

 
$
(0.3
)
 
$
56.7

 
December 31, 2016
 
 
 
Gross
 
Gross
 
 
 
Cost
 
Unrealized
 
Unrealized
 
Fair
 
Basis
 
Gains
 
Losses
 
Value
Description:
 
 
 
 
 
 
 
U.S. Treasuries
$
1.0

 
$

 
$

 
$
1.0

Corporate bonds/Fixed income
28.3

 

 

 
28.3

Corporate equity
14.4

 
0.1

 
(0.3
)
 
14.2

Total available-for-sale securities
$
43.7

 
$
0.1

 
$
(0.3
)
 
$
43.5


As of September 30, 2017, available-for-sale securities included U.S. Treasuries, corporate bonds and fixed income securities of $3.5 million with contractual maturities within one year and $39.7 million with contractual maturities extending longer than one year through five years and $1.3 million with contractual maturities extending longer than five years. Actual maturities may differ from contractual maturities as a result of the Company's ability to sell these securities prior to maturity.

The Company's available-for-sale investment securities that were temporarily impaired as of September 30, 2017 and December 31, 2016 were as follows (in millions):
 
September 30, 2017
 
December 31, 2016
 
Fair
 
Unrealized
 
Fair
 
Unrealized
 
Value
 
Loss
 
Value
 
Loss
Description:
 
 
 
 
 
 
 
Corporate bonds/Fixed income
$
13.3

 
$
(0.2
)
 
$

 
$

Corporate equity
0.2

 
(0.1
)
 
7.6

 
(0.3
)
 
$
13.5

 
$
(0.3
)
 
$
7.6

 
$
(0.3
)

There were no available-for-sale investment securities that were other-than-temporarily impaired as of September 30, 2017.

19